1. A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway. Issue 4 (13th July 2018) Authors: Bartko, Johann; Schoergenhofer, Christian; Schwameis, Michael; Firbas, Christa; Beliveau, Martin; Chang, Colin; Marier, Jean‐Francois; Nix, Darrell; Gilbert, James C.; Panicker, Sandip; Jilma, Bernd Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 4(2018) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics, Pharmacodynamics, and Exposure‐Response of Lanadelumab for Hereditary Angioedema. Issue 6 (26th May 2020) Authors: Wang, Yi; Marier, Jean-Francois; Kassir, Nastya; Chang, Colin; Martin, Patrick Journal: Clinical and translational science Issue: Volume 13:Issue 6(2020) Page Start: 1208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗